Cargando…

Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT(1A) Receptor Biased Agonist

Depression is the most prevalent of the mental illnesses and serotonin (5-hydroxytryptamine, 5-HT) is considered to be the major neurotransmitter involved in its etiology and treatment. In this context, 5-HT(1A) receptors have attracted interest as targets for therapeutic intervention. Notably the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabanu, Sharon, Pilar-Cuéllar, Fuencisla, Zubakina, Paula, Florensa-Zanuy, Eva, Senserrich, Júlia, Newman-Tancredi, Adrian, Adell, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954942/ https://www.ncbi.nlm.nih.gov/pubmed/35337135 http://dx.doi.org/10.3390/ph15030337

Ejemplares similares

The 5-HT(1A) receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models
por: Papp, Mariusz, et al.
Publicado: (2023)

Multimodal imaging study of the 5-HT(1A) receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia
por: Chaib, Sarah, et al.
Publicado: (2023)

The selective 5-HT(1A) receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets
por: Fisher, Ria, et al.
Publicado: (2020)

mTOR Knockdown in the Infralimbic Cortex Evokes A Depressive-like State in Mouse
por: Garro-Martínez, Emilio, et al.
Publicado: (2021)

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study
por: Pascual-Antón, Raquel, et al.
Publicado: (2021)

Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
por: Gordillo-Salas, Marta, et al.
Publicado: (2018)

The selective 5-HT(1A) receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress
por: Głuch-Lutwin, Monika, et al.
Publicado: (2021)

Selective serotonin 5-HT(1A) receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study
por: Becker, G., et al.
Publicado: (2016)

Anti-aggressive effects of the selective high-efficacy ‘biased’ 5-HT(1A) receptor agonists F15599 and F13714 in male WTG rats
por: de Boer, Sietse F., et al.
Publicado: (2015)

5-HT(4) Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression
por: Amigo, Josep, et al.
Publicado: (2021)

Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT(1A) agonists
por: Abdala, Ana P., et al.
Publicado: (2014)

5-HT Receptors and the Development of New Antidepressants
por: Ślifirski, Grzegorz, et al.
Publicado: (2021)

Neural Plasticity and Proliferation in the Generation of Antidepressant Effects: Hippocampal Implication
por: Pilar-Cuéllar, Fuencisla, et al.
Publicado: (2013)

Marmoset Serotonin 5-HT(1A) Receptor Mapping with a Biased Agonist PET Probe (18)F-F13714: Comparison with an Antagonist Tracer (18)F-MPPF in Awake and Anesthetized States
por: Yokoyama, Chihiro, et al.
Publicado: (2016)

In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
por: Schweimer, Judith V., et al.
Publicado: (2022)

Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT(6) partial agonist in rats
por: Jastrzębska-Więsek, Magdalena, et al.
Publicado: (2016)

Role of 5-HT(3) Receptors in the Antidepressant Response
por: Bétry, Cécile, et al.
Publicado: (2011)

Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT(1A) Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile
por: Sniecikowska, Joanna, et al.
Publicado: (2020)

Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT(2A) Receptor Agonists
por: Poulie, Christian B. M., et al.
Publicado: (2022)

Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT(1A) Receptor Agonist
por: Chen, Hong-xia, et al.
Publicado: (2013)

Study on the effect of EMD386088, a 5-HT(6) receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats
por: Jastrzębska-Więsek, Magdalena, et al.
Publicado: (2017)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Structure–Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT(2A) Receptor Agonists
por: Pottie, Eline, et al.
Publicado: (2023)

[(18)F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT(1A) receptors in humans
por: Courault, Pierre, et al.
Publicado: (2023)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT(1A) and 5-HT(7) Antagonists in Animal Models
por: Pytka, Karolina, et al.
Publicado: (2015)

The 5-HT(1B) receptor - a potential target for antidepressant treatment
por: Tiger, Mikael, et al.
Publicado: (2018)

Towards in vivo imaging of functionally active 5-HT(1A) receptors in schizophrenia: concepts and challenges
por: Razakarivony, Oriane, et al.
Publicado: (2021)

The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions
por: Gardier, Alain M.
Publicado: (2013)

Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR
por: Zilberg, Gregory, et al.
Publicado: (2023)

Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats
por: Yu, Haining, et al.
Publicado: (2017)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

The Effect of Serotonin-Targeting Antidepressants on Neurogenesis and Neuronal Maturation of the Hippocampus Mediated via 5-HT1A and 5-HT4 Receptors
por: Segi-Nishida, Eri
Publicado: (2017)

Dibenzofuranylethylamines as 5-HT(2A/2C) Receptor Agonists
por: Yempala, Thirumal, et al.
Publicado: (2020)

Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

A single channel mutation alters agonist efficacy at 5-HT(3)A and 5-HT(3)AB receptors
por: Thompson, A J, et al.
Publicado: (2013)

Emergence of 5-HT5A signaling in parvalbumin neurons mediates delayed antidepressant action
por: Sagi, Yotam, et al.
Publicado: (2019)

DSP-1053, a novel serotonin reuptake inhibitor with 5-HT(1A) partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats
por: Kato, Taro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5eep547b65hm4s4npeb6l4t69h